Is TTRX up or down today?
TTRX is down 2.69% today, last at 13.38. This stock moved -2.69% versus the prior close.
TTRX · TTRX
TTRX (TTRX) is trading at 13.38, down 2.69% on the session. TTRX sits at the 45% mark of its 52-week range, carries a 14-day RSI of 73, and trades above its 50-day average. Over the past month it is up 30.92%.
Leading the coverage: “Turn (TTRX) Levels: Records a 2.33% Increase to $9.68 in the Current Update; Levels: $9.20 and $10.16 Define the Nearby Reference Levels in the Latest Session - Flat Correction - dars.gov.et” (Google News, 17d ago). TTRX is +4.02% since story.
TTRX trades on a trailing P/E of 18.3 and is running 32.89% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
TTRX is down 2.69% today, last at 13.38. This stock moved -2.69% versus the prior close.
Leading the coverage: “Turn (TTRX) Levels: Records a 2.33% Increase to $9.68 in the Current Update; Levels: $9.20 and $10.16 Define the Nearby Reference Levels in the Latest Session - Flat Correction - dars.gov.et” (Google News, 17d ago). TTRX is +4.02% since story. Dominant story: Turn Therapeutics (TTRX) Advances 3.82% to $8.56 as Biotech Buying Interest Intensifies - Value ETF - vinanet.vn (4 sources, neutral) RSI is 73 — overbought (heated) Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Turn Therapeutics to Present Atopic Dermatitis Strategy - TipRanks
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
Turn Therapeutics Names Robert Redfield Chief Scientific Officer - TipRanks
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
Market Movers | Winners: TTRX, ORBS, NUAI | Losers: DYN, SGML, XFOR - Trefis